4basebio PLC (88Q.DE)
EUR 14.6
(0.0%)
EUR 14.6
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 332 Thousand GBP | 149.62% |
| 2022 | 133 Thousand GBP | -14.74% |
| 2021 | 156 Thousand GBP | 19.08% |
| 2020 | 131 Thousand GBP | 28.43% |
| 2019 | 102 Thousand GBP | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q4 | 332 Thousand GBP | 66.83% |
| 2023 FY | 332 Thousand GBP | 149.62% |
| 2023 Q2 | 199 Thousand GBP | 49.62% |
| 2022 FY | 133 Thousand GBP | -14.74% |
| 2022 Q4 | 133 Thousand GBP | -10.14% |
| 2022 Q2 | 148 Thousand GBP | -5.13% |
| 2021 FY | 156 Thousand GBP | 19.08% |
| 2021 Q4 | 156 Thousand GBP | 54.46% |
| 2021 Q2 | 101 Thousand GBP | -22.9% |
| 2020 Q4 | 131 Thousand GBP | -9.03% |
| 2020 FY | 131 Thousand GBP | 28.43% |
| 2020 Q2 | 144 Thousand GBP | 0.0% |
| 2019 FY | 102 Thousand GBP | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| BioNTech SE | 357.7 Million EUR | 99.907% |
| CureVac N.V. | 24.82 Million EUR | 98.662% |
| Biotest Aktiengesellschaft | 419.1 Million EUR | 99.921% |
| Biotest Aktiengesellschaft | 419.1 Million EUR | 99.921% |
| BRAIN Biotech AG | 9.72 Million EUR | 96.586% |
| Formycon AG | 467 Thousand EUR | 28.908% |
| Heidelberg Pharma AG | 10.48 Million EUR | 96.834% |
| Medigene AG | 1.00 EUR | -33199900.0% |